Clinical Trials
2 trialsNCT01534585 2018-04-17
Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma
Taizhou Hospital
Phase 1/2 Completed
NCT02328261 2014-12-31
A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal Carcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown